These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6610103)
41. [Effects of serum immunosuppressive factors on the cytotoxicity of lymphokine-activated killer (LAK) cells induced by recombinant interleukin 2(R-IL2)]. Takao H; Saji S; Sugiyama Y; Tachibana S; Goshima H; Kunii Y; Sakata K Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):992-8. PubMed ID: 2975748 [TBL] [Abstract][Full Text] [Related]
42. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers. Nio Y; Zighelboim J; Berek JS; Bonavida B Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516 [TBL] [Abstract][Full Text] [Related]
43. The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients. Yanagawa E; Toge T; Sawamura A; Kegoya Y; Baba N; Hattori T Jpn J Surg; 1988 Nov; 18(6):660-7. PubMed ID: 2977625 [TBL] [Abstract][Full Text] [Related]
44. Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma. Akiyoshi T; Koba F; Arinaga S; Wada T; Tsuji H Jpn J Surg; 1988 Mar; 18(2):164-71. PubMed ID: 2969062 [TBL] [Abstract][Full Text] [Related]
45. Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF). Kedar E; Ikejiri BL; Timonen T; Bonnard GD; Reid J; Navarro NJ; Sredni B; Herberman RB Eur J Cancer Clin Oncol; 1983 Jun; 19(6):757-73. PubMed ID: 6603361 [TBL] [Abstract][Full Text] [Related]
46. [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients]. Gotoh K Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1600-7. PubMed ID: 3878935 [TBL] [Abstract][Full Text] [Related]
47. [Effect of splenic mononuclear cells on autochthonous peripheral blood lymphocyte responses to mitogens in gastric cancer patients]. Kurosu Y; Fukamachi S; Tanaka N; Nakanishi H; Arai T; Matsumoto S; Yasui E; Morita K Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):965-9. PubMed ID: 6676667 [TBL] [Abstract][Full Text] [Related]
48. [Immunological significance of splenectomy in gastric cancer surgery. Production of immunosuppressive factor in the spleen]. Kanayama H; Oda M; Karino T; Yamane T; Hamazoe R; Osaki Y; Shimizu N; Maeta M; Koga S Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):952-6. PubMed ID: 6676666 [TBL] [Abstract][Full Text] [Related]
49. [Inhibition of NK activity by oses: effect of interleukin 2 (author's transl)]. Vie H; Ythier A; Moreau JF; Peyrat MA; Soulillou JP Ann Immunol (Paris); 1981; 132C(3):327-37. PubMed ID: 6174070 [TBL] [Abstract][Full Text] [Related]
50. [Cytotoxicity of interleukin 2-induced lymphocytes and effects of serum immunosuppressive factors]. Sugiyama Y; Takao H; Umemoto T; Niwa H; Kida H; Saji S; Sakata K Nihon Geka Gakkai Zasshi; 1986 Jan; 87(1):3-9. PubMed ID: 3007973 [TBL] [Abstract][Full Text] [Related]
51. Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma. Brenner BG; Benarrosh S; Margolese RG Cancer; 1986 Aug; 58(4):895-902. PubMed ID: 3487379 [TBL] [Abstract][Full Text] [Related]
52. The effect of cimetidine on PBL from healthy donors and melanoma patients: augmentation of T cell responses to TCGF mitogens and alloantigens and of TCGF production. Eisenthal A; Monselise J; Zinger R; Adler A Cancer Immunol Immunother; 1986; 21(2):141-7. PubMed ID: 2936446 [TBL] [Abstract][Full Text] [Related]
53. Preoperative cell-mediated immune function and the prognosis of patients with gastric carcinoma. Akiyoshi T; Koba F; Arinaga S; Ueo H J Surg Oncol; 1990 Nov; 45(3):137-42. PubMed ID: 2232803 [TBL] [Abstract][Full Text] [Related]
54. Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma. Koba F; Akiyoshi T; Arinaga S; Wada T; Tsuji H Jpn J Surg; 1987 Mar; 17(2):83-90. PubMed ID: 2957537 [TBL] [Abstract][Full Text] [Related]
55. In vivo modulating effects of bacterial peptidoglycans on PHA-induced responses of porcine PBL and splenocytes. Vijtiuk N; Kosuta D; Basić I; Valpotić I Immunobiology; 1993 Jul; 188(3):274-80. PubMed ID: 8225389 [TBL] [Abstract][Full Text] [Related]
56. Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells. Rey A; Klein B; Zagury D; Thierry C; Serrou B Immunol Lett; 1983 Mar; 6(3):175-8. PubMed ID: 6602761 [TBL] [Abstract][Full Text] [Related]
57. Regulation of innate immunity in tilapia: activation of nonspecific cytotoxic cells by cytokine-like factors. Jaso-Friedmann L; Ruiz J; Bishop GR; Evans DL Dev Comp Immunol; 2000 Jan; 24(1):25-36. PubMed ID: 10689096 [TBL] [Abstract][Full Text] [Related]
58. Prothymosin alpha restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer. Baxevanis CN; Reclos GJ; Papamichail M Int J Cancer; 1993 Jan; 53(2):264-8. PubMed ID: 8425763 [TBL] [Abstract][Full Text] [Related]
59. Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer. Kuwahara Y; Kusugami K; Morise K; Shimokata K Gastroenterol Jpn; 1987 Aug; 22(4):428-34. PubMed ID: 3117611 [TBL] [Abstract][Full Text] [Related]
60. Cultured human T-cell lines kill autologous solid tumours. Vose BM; Moore M Immunol Lett; 1981 Oct; 3(4):237-41. PubMed ID: 6975752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]